Showing results (11-20 of 2,985) with videos related to
Sort By:
Pageof 299
Ecancermedicalscience|July 31, 2014
Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentPan Pantziarka, Gauthier Bouche, Lydie Meheus, et al.Cancer Journal (Sudbury, Mass.)|March 22, 2019
Repurposing Food and Drug Administration-Approved Drugs to Promote Antitumor ImmunityVidula V Sukhatme, Suresh S Ramalingam, Rafi Ahmed, et al.Ecancermedicalscience|October 6, 2015
Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agentVidula Sukhatme, Gauthier Bouche, Lydie Meheus, et al.Biometrics|October 23, 1997
Receiver operating characteristic studies and measurement errorsM Coffin, S SukhatmeFrontiers in Pharmacology|May 7, 2021
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19Vikas P Sukhatme, Angela M Reiersen, Sharat J Vayttaden, et al.Ecancermedicalscience|May 11, 2018
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agentsPan Pantziarka, Vidula Sukhatme, Sergio Crispino, et al.Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|January 7, 2003
Decay of passive scalars under the action of single scale smooth velocity fields in bounded two-dimensional domains: from non-self-similar probability distribution functions to self-similar eigenmodesJai Sukhatme, Raymond T PierrehumbertEcancermedicalscience|December 1, 2016
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentPan Pantziarka, Gauthier Bouche, Vidula Sukhatme, et al.Ecancermedicalscience|July 31, 2014
The Repurposing Drugs in Oncology (ReDO) ProjectPan Pantziarka, Gauthier Bouche, Lydie Meheus, et al.Pageof 299